According to The State of Legal Marijuana Markets report, released mid-2018 by Arcview Market Research and BDS Analytics, the legal cannabis business in the United States is projected to be a $23 billion industry by 2022. And, Little Italy-headquartered Cannabiniers, a cannabis brand management company, wants a piece of the pie.
Scripps Mercy Hospital San Diego landed a $260,000 grant for opioid disorder treatment, the California Bridge Program recently announced.
ENVIRONMENT: BlueNalu Puts A Biotech Twist on Catching Dinner
To satisfy the world’s growing appetite for seafood, one San Diego company is exploring laboratories rather than the ocean.
San Diego-based Amplyx Pharmaceuticals’ lead drug candidate received an orphan drug designation for a condition that can be life-threatening for HIV/AIDs patients and others.
REAL ESTATE: Raw Land Scarce, Reuse Eyed in North County
Despite the shrinking inventory of raw land, demand for North County property is going strong, with low vacancy rates for industrial and office property.
AMN Healthcare recently reported $529 million in fourth quarter revenue, a 4 percent year-over-year increase. San Diego-based AMN is the country’s largest health care staffing agency.
BIOTECH: M&A in the Air at Contract Research Organizations
A crop of San Diego companies quietly play niche roles in drug development. But suitors have taken notice.
A recent report stated that Smith & Nephew Plc has held talks to buy San Diego spine surgery company NuVasive. But analysts largely said the deal doesn’t make sense for the British firm.
The 350 attendees are proven men and women of action.
Gossamer Bio — a closely watched San Diego biotech during the government shutdown — made its public debut Feb. 8 with an upsized $276 million offering.
BIOTECH: Why Pay More Is One Company’s Philosophy
When Ionis Pharmaceuticals was looking for a new home, it chose Carlsbad over the more traditional sites for life science companies in central San Diego County.
San Diego-based Cibus postponed its initial public offering, citing “current market and technical conditions.”
San Diego-based Arcturus Therapeutics on Feb. 12 reassumed full rights to its flagship drug candidate, after CureVac opted out of development plans.
Through a joint venture Scripps Health has planned a 120-bed behavioral health facility in Chula Vista that will replace a smaller behavioral health unit at Scripps Mercy Hospital.
Qualcomm Life was sold to private equity firm Francisco Partners. It will be renamed Capsule Technologies.